These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 16755567)

  • 1. mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models.
    Weizer-Stern O; Adamsky K; Amariglio N; Rachmilewitz E; Breda L; Rivella S; Rechavi G
    Am J Hematol; 2006 Jul; 81(7):479-83. PubMed ID: 16755567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.
    Hendy OM; Allam M; Allam A; Attia MH; El Taher S; Eldin MM; Ali A
    Egypt J Immunol; 2010; 17(2):33-44. PubMed ID: 23082485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous iron increases hemoglobin in beta-thalassemic mice.
    Ginzburg YZ; Rybicki AC; Suzuka SM; Hall CB; Breuer W; Cabantchik ZI; Bouhassira EE; Fabry ME; Nagel RL
    Exp Hematol; 2009 Feb; 37(2):172-83. PubMed ID: 19059700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.
    Schmidt PJ; Toudjarska I; Sendamarai AK; Racie T; Milstein S; Bettencourt BR; Hettinger J; Bumcrot D; Fleming MD
    Blood; 2013 Feb; 121(7):1200-8. PubMed ID: 23223430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver expression of hepcidin and other iron genes in two mouse models of beta-thalassemia.
    De Franceschi L; Daraio F; Filippini A; Carturan S; Muchitsch EM; Roetto A; Camaschella C
    Haematologica; 2006 Oct; 91(10):1336-42. PubMed ID: 17018382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
    Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
    Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia.
    Nai A; Pagani A; Mandelli G; Lidonnici MR; Silvestri L; Ferrari G; Camaschella C
    Blood; 2012 May; 119(21):5021-9. PubMed ID: 22490684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin.
    Gardenghi S; Marongiu MF; Ramos P; Guy E; Breda L; Chadburn A; Liu Y; Amariglio N; Rechavi G; Rachmilewitz EA; Breuer W; Cabantchik ZI; Wrighting DM; Andrews NC; de Sousa M; Giardina PJ; Grady RW; Rivella S
    Blood; 2007 Jun; 109(11):5027-35. PubMed ID: 17299088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia.
    Kautz L; Jung G; Du X; Gabayan V; Chapman J; Nasoff M; Nemeth E; Ganz T
    Blood; 2015 Oct; 126(17):2031-7. PubMed ID: 26276665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepcidin independent iron recycling in a mouse model of β-thalassaemia intermedia.
    Frazer DM; Wilkins SJ; Mirciov CS; Dunn LA; Anderson GJ
    Br J Haematol; 2016 Oct; 175(2):308-317. PubMed ID: 27410488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of hepcidin and haemojuvelin expression in the hepatocyte cell-line HepG2 induced by thalassaemic sera.
    Weizer-Stern O; Adamsky K; Amariglio N; Levin C; Koren A; Breuer W; Rachmilewitz E; Breda L; Rivella S; Cabantchik ZI; Rechavi G
    Br J Haematol; 2006 Oct; 135(1):129-38. PubMed ID: 16939499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global loss of Tfr2 with concomitant induced iron deficiency greatly ameliorates the phenotype of a murine thalassemia intermedia model.
    Schmidt PJ; Fitzgerald K; Butler JS; Fleming MD
    Am J Hematol; 2021 Feb; 96(2):251-257. PubMed ID: 33180328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasis.
    Gutschow P; Schmidt PJ; Han H; Ostland V; Bartnikas TB; Pettiglio MA; Herrera C; Butler JS; Nemeth E; Ganz T; Fleming MD; Westerman M
    Haematologica; 2015 Feb; 100(2):167-77. PubMed ID: 25425686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepcidin and Hfe in iron overload in beta-thalassemia.
    Gardenghi S; Ramos P; Follenzi A; Rao N; Rachmilewitz EA; Giardina PJ; Grady RW; Rivella S
    Ann N Y Acad Sci; 2010 Aug; 1202():221-5. PubMed ID: 20712796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice.
    Gardenghi S; Ramos P; Marongiu MF; Melchiori L; Breda L; Guy E; Muirhead K; Rao N; Roy CN; Andrews NC; Nemeth E; Follenzi A; An X; Mohandas N; Ginzburg Y; Rachmilewitz EA; Giardina PJ; Grady RW; Rivella S
    J Clin Invest; 2010 Dec; 120(12):4466-77. PubMed ID: 21099112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulated erythropoiesis with secondary iron loading leads to a decrease in hepcidin despite an increase in bone morphogenetic protein 6 expression.
    Frazer DM; Wilkins SJ; Darshan D; Badrick AC; McLaren GD; Anderson GJ
    Br J Haematol; 2012 Jun; 157(5):615-26. PubMed ID: 22449175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNAi-mediated reduction of hepatic Tmprss6 diminishes anemia and secondary iron overload in a splenectomized mouse model of β-thalassemia intermedia.
    Schmidt PJ; Liu K; Visner G; Fitzgerald K; Fishman S; Racie T; Hettinger JL; Butler JS; Fleming MD
    Am J Hematol; 2018 Jun; 93(6):745-750. PubMed ID: 29498084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait.
    Jones E; Pasricha SR; Allen A; Evans P; Fisher CA; Wray K; Premawardhena A; Bandara D; Perera A; Webster C; Sturges P; Olivieri NF; St Pierre T; Armitage AE; Porter JB; Weatherall DJ; Drakesmith H
    Blood; 2015 Jan; 125(5):873-80. PubMed ID: 25519750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transferrin receptor 2 (Tfr2) genetic deletion makes transfusion-independent a murine model of transfusion-dependent β-thalassemia.
    Di Modica SM; Tanzi E; Olivari V; Lidonnici MR; Pettinato M; Pagani A; Tiboni F; Furiosi V; Silvestri L; Ferrari G; Rivella S; Nai A
    Am J Hematol; 2022 Oct; 97(10):1324-1336. PubMed ID: 36071579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased hepcidin expression in murine β-thalassemia is associated with suppression of Bmp/Smad signaling.
    Parrow NL; Gardenghi S; Ramos P; Casu C; Grady RW; Anderson ER; Shah YM; Li H; Ginzburg YZ; Fleming RE; Rivella S
    Blood; 2012 Mar; 119(13):3187-9. PubMed ID: 22461476
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.